(VIANEWS) – UBS Group (UBS), NV5 Global (NVEE), Rollins (ROL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. UBS Group (UBS)
47% sales growth and 11.27% return on equity
UBS Group AG provides financial advice and solutions to private, institutional, and corporate clients worldwide. It operates through four divisions: Global Wealth Management, Personal & Corporate Banking, Asset Management, and Investment Bank. The Global Wealth Management division offers investment advice and solutions, and lending solutions. This segment also provides estate and wealth planning, investing, corporate and banking, and investment management, as well as mortgage, securities-based, and structured lending solutions. The Personal & Corporate Banking division provides personal banking products and services, such as deposits, cards, and online and mobile banking, as well as lending, investments, and retirement services; and corporate and institutional solutions, including equity and debt capital markets, syndicated and structured credit, private placements, leasing, traditional financing, trade and export finance, and global custody solutions, as well as transaction banking solutions for payment and cash management. The Asset Management division offers equities, fixed income, hedge funds, real estate and private markets, indexed and alternative beta strategies, asset allocation and currency investment strategies, customized multi-asset solutions, advisory and fiduciary services, and multi-manager hedge fund solutions and advisory services. The Investment Bank division advises clients on strategic business opportunities and helps them raise capital to fund their activities; enables its clients to buy, sell, and finance securities on capital markets and to manage their risks and liquidity; distribute, trade, finance, and clear cash equities and equity-linked products; and offers clients differentiated content on major financial markets and securities. The company was formerly known as UBS AG and changed its name to UBS Group AG in December 2014. UBS Group AG was founded in 1862 and is based in Zurich, Switzerland.
Earnings Per Share
As for profitability, UBS Group has a trailing twelve months EPS of $10.33.
PE Ratio
UBS Group has a trailing twelve months price to earnings ratio of 2.48. Meaning, the purchaser of the share is investing $2.48 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.27%.
Sales Growth
UBS Group’s sales growth is 43.7% for the current quarter and 47% for the next.
Moving Average
UBS Group’s value is way above its 50-day moving average of $21.15 and way higher than its 200-day moving average of $20.15.
Yearly Top and Bottom Value
UBS Group’s stock is valued at $25.61 at 01:22 EST, above its 52-week high of $23.74.
Previous days news about UBS Group(UBS)
- According to Zacks on Monday, 11 September, "In addition, Zacks Equity Research provides analysis on The Goldman Sachs Group, Inc. (GS Quick QuoteGS – Free Report) , UBS Group AG (UBS Quick QuoteUBS – Free Report) and The Charles Schwab Corp. (SCHW Quick QuoteSCHW – Free Report) .", "Similar to Goldman, UBS Group AG andThe Charles Schwab Corp. have been reducing their workforce."
2. NV5 Global (NVEE)
24.1% sales growth and 6.48% return on equity
NV5 Global, Inc. provides professional and technical engineering and consulting services to public and private sector clients in the infrastructure, utility services, construction, real estate, and environmental markets in the United States and internationally. It operates through three segments: Infrastructure; Building, Technology & Sciences; and Geospatial Solutions. The company offers site selection and planning, design, water resources, transportation, structural engineering, land development, surveying, power delivery, building code compliance, and other services; and construction materials testing and engineering, geotechnical engineering and consulting, and forensic consulting services. It also provides governmental outsourcing and consulting, and technical outsourcing services; and geospatial data analytic and mapping services. In addition, the company offers mechanical, electrical, and plumbing design; commissioning; energy performance, management, and optimization; building program management; acoustical design consulting; and audiovisual–security and surveillance–information technology–data center services, as well as energy services. Further, it provides various services, such as investigating and analyzing environmental conditions, and recommending corrective measures and procedures; occupational health and safety services; radiation exposure and protection, and nuclear safety and industrial hygiene analyses services; hydrogeological modeling and environmental programs; water resource planning, monitoring, and environmental management of wastewater facilities; solid waste landfill investigations; permitting and compliance; storm water pollution; environmental impact statement support; agricultural waste management and permitting; and wetland evaluations. The company was formerly known as NV5 Holdings, Inc. and changed its name to NV5 Global, Inc. in December 2015. NV5 Global, Inc. was founded in 1949 and is headquartered in Hollywood, Florida.
Earnings Per Share
As for profitability, NV5 Global has a trailing twelve months EPS of $2.89.
PE Ratio
NV5 Global has a trailing twelve months price to earnings ratio of 33.03. Meaning, the purchaser of the share is investing $33.03 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.48%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 9.8%, now sitting on 800.85M for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 4% and positive 24% for the next.
Yearly Top and Bottom Value
NV5 Global’s stock is valued at $95.47 at 01:22 EST, way below its 52-week high of $154.97 and above its 52-week low of $89.30.
Volume
Today’s last reported volume for NV5 Global is 54004 which is 42.53% below its average volume of 93978.
3. Rollins (ROL)
12.2% sales growth and 31.48% return on equity
Rollins, Inc., through its subsidiaries, provides pest and wildlife control services to residential and commercial customers in the United States and internationally. The company offers pest control services to residential properties protecting from common pests, including rodents, insects, and wildlife. It also provides workplace pest control solutions for customers across various end markets, such as healthcare, foodservice, and logistics. In addition, the company offers termite protection services and ancillary services. It serves clients directly, as well as through franchisee operations. Rollins, Inc. was incorporated in 1948 and is headquartered in Atlanta, Georgia.
Earnings Per Share
As for profitability, Rollins has a trailing twelve months EPS of $0.79.
PE Ratio
Rollins has a trailing twelve months price to earnings ratio of 46.05. Meaning, the purchaser of the share is investing $46.05 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.48%.
Moving Average
Rollins’s value is way under its 50-day moving average of $41.40 and under its 200-day moving average of $39.10.
Yearly Top and Bottom Value
Rollins’s stock is valued at $36.38 at 01:22 EST, way below its 52-week high of $45.04 and higher than its 52-week low of $34.20.
Volume
Today’s last reported volume for Rollins is 2496610 which is 38.39% above its average volume of 1803960.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 13.6% and 23.5%, respectively.
Previous days news about Rollins(ROL)
- According to VentureBeat on Monday, 11 September, "We’re also retaining them and making sure that we are looking at every step of the way in the life cycle and being able to target them," Rollins says. ", "An effort we’re also looking at here at Typeform is making sure that the content, from the minute that you acquire a customer, all the way through the funnel and the life cycle, it stays true to them," Rollins says. "
4. Capital Product Partners L.P. (CPLP)
12% sales growth and 16.05% return on equity
Capital Product Partners L.P., a shipping company, provides marine transportation services in Greece. Its vessels transports a range of dry cargoes and containerized goods under short-term voyage charters, and medium to long-term time and bareboat charters. As of April 26, 2021, the company owned 17 vessels, including thirteen Neo-Panamax container vessels, three Panamax container vessels, and one Capesize bulk carrier. Capital GP L.L.C. serves as the general partner of the company. The company was incorporated in 2007 and is headquartered in Piraeus, Greece.
Earnings Per Share
As for profitability, Capital Product Partners L.P. has a trailing twelve months EPS of $4.78.
PE Ratio
Capital Product Partners L.P. has a trailing twelve months price to earnings ratio of 3.04. Meaning, the purchaser of the share is investing $3.04 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.05%.
5. TPG Specialty Lending (TSLX)
11.4% sales growth and 13.82% return on equity
Sixth Street Specialty Lending, Inc. (NYSE: TSLX) is a business development company. The fund provides senior secured loans (first-lien, second-lien, and unitranche), unsecured loans, mezzanine debt, and investments in corporate bonds and equity securities and structured products, non-control structured equity, and common equity with a focus on co-investments for organic growth, acquisitions, market or product expansion, restructuring initiatives, recapitalizations, and refinancing. The fund invests in business services, software & technology, healthcare, energy, consumer & retail, manufacturing, industrials, royalty related businesses, education, and specialty finance. It seeks to finance and lending to middle market companies principally located in the United States. The fund invests in companies with enterprise value between $50 million and $1 billion or more and EBITDA between $10 million and $250 million. The transaction size is between $15 million and $350 million. The fund invests across the spectrum of the capital structure and can arrange syndicated transactions of up to $500 million and hold sizeable positions within its credits.
Earnings Per Share
As for profitability, TPG Specialty Lending has a trailing twelve months EPS of $2.3.
PE Ratio
TPG Specialty Lending has a trailing twelve months price to earnings ratio of 8.71. Meaning, the purchaser of the share is investing $8.71 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.82%.
Sales Growth
TPG Specialty Lending’s sales growth is 44.7% for the current quarter and 11.4% for the next.
Moving Average
TPG Specialty Lending’s worth is higher than its 50-day moving average of $19.72 and above its 200-day moving average of $18.68.
Yearly Top and Bottom Value
TPG Specialty Lending’s stock is valued at $20.03 at 01:22 EST, below its 52-week high of $20.97 and way higher than its 52-week low of $16.02.
Volume
Today’s last reported volume for TPG Specialty Lending is 106885 which is 68.27% below its average volume of 336932.
6. Abercrombie & Fitch Company (ANF)
10.5% sales growth and 16.06% return on equity
Abercrombie & Fitch Co., through its subsidiaries, operates as a specialty retailer. The company operates in two segments, Hollister and Abercrombie. It offers an assortment of apparel, personal care products, intimates, and accessories for men, women, and children under the Hollister, Abercrombie & Fitch, abercrombie kids, Moose, Seagull, and Gilly Hicks brands. As of May 28, 2020, it operated approximately 850 stores in North America, Europe, Asia, and the Middle East. The company sells products through its stores and direct-to-consumer channels; various third-party wholesale, franchise, and licensing arrangements; and e-commerce platforms. Abercrombie & Fitch Co. was founded in 1892 and is headquartered in New Albany, Ohio.
Earnings Per Share
As for profitability, Abercrombie & Fitch Company has a trailing twelve months EPS of $2.16.
PE Ratio
Abercrombie & Fitch Company has a trailing twelve months price to earnings ratio of 25.23. Meaning, the purchaser of the share is investing $25.23 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.06%.
Volume
Today’s last reported volume for Abercrombie & Fitch Company is 1196360 which is 37.09% below its average volume of 1901760.
Moving Average
Abercrombie & Fitch Company’s worth is way above its 50-day moving average of $40.40 and way higher than its 200-day moving average of $30.01.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 10600% and 123.5%, respectively.
7. CVS Health (CVS)
7.8% sales growth and 3.81% return on equity
CVS Health Corporation provides health services in the United States. It operates through Health Care Benefits, Pharmacy Services, and Retail/LTC segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.
Earnings Per Share
As for profitability, CVS Health has a trailing twelve months EPS of $2.19.
PE Ratio
CVS Health has a trailing twelve months price to earnings ratio of 30.2. Meaning, the purchaser of the share is investing $30.2 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.81%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 10.1%, now sitting on 338.07B for the twelve trailing months.
Volume
Today’s last reported volume for CVS Health is 2949050 which is 68.79% below its average volume of 9449410.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jul 19, 2023, the estimated forward annual dividend rate is 2.42 and the estimated forward annual dividend yield is 3.68%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
CVS Health’s EBITDA is 0.44.
8. Cemex, S.A.B. de C.V. Sponsored ADR (CX)
7.4% sales growth and 5.27% return on equity
CEMEX, S.A.B. de C.V., together with its subsidiaries, produces, markets, distributes, and sells cement, ready-mix concrete, aggregates, clinker, and other construction materials worldwide. The company also offers various complementary construction products, including asphalt products; concrete blocks; roof tiles; architectural products; concrete pipes for storm and sanitary sewers applications; and other precast products, such as rail products, concrete floors, box culverts, bridges, drainage basins, barriers, and parking curbs. In addition, it provides building solutions for housing projects, pavement projects, and green building consultancy services; cement trade maritime services; and information technology solutions. The company operates approximately 2,000 retail stores in approximately 600 cities. CEMEX, S.A.B. de C.V. was founded in 1906 and is headquartered in San Pedro Garza GarcÃa, Mexico.
Earnings Per Share
As for profitability, Cemex, S.A.B. de C.V. Sponsored ADR has a trailing twelve months EPS of $1.58.
PE Ratio
Cemex, S.A.B. de C.V. Sponsored ADR has a trailing twelve months price to earnings ratio of 5.11. Meaning, the purchaser of the share is investing $5.11 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.27%.
